Previous 10 | Next 10 |
NEW YORK , April 7, 2020 /PRNewswire/ -- LivePerson Founder and CEO Robert Locascio published a letter to the LivePerson community, including employees, customers, shareholders, to mark the company's 20th anniversary of becoming a public company. LivePerson, Inc . (Nasdaq: LPSN)...
LivePerson, Inc. ( LPSN ) is a company that has been beaten down more than most during the recent stock market crash. A few weeks ago the stock price was ~$46. The stock recently closed at $19.50 for a drop of 57%. (Source: Yahoo Finance/MS Paint) While I sympathize with existing shareho...
Shares of Zoom Video Communications , Teladoc Health , and LivePerson surged on Monday after investors bet the three companies would do well as remote work and social distancing become the norm as the novel coronavirus spreads globally. As the outbreak expands in the United States, mul...
NEW YORK , March 10, 2020 /PRNewswire/ -- LivePerson, Inc . (Nasdaq: LPSN), a global leader in conversational solutions, has been named to Fast Company 's prestigious annual list of the World's Most Innovative Companies for 2020. The list honors the businesses ...
LivePerson, Inc. (LPSN) Q4 2019 Results Conference Call February 13, 2020 05:00 PM ET Company Participants Matthew Kempler - Senior Vice President of Investor Relations and Planning Robert LoCascio - Founder and Chief Executive Officer Chris Greiner - Chief Financial Officer Jo...
The following slide deck was published by LivePerson, Inc. in conjunction with their 2019 Q4 earnings Read more ...
Gainers : BioXcel Therapeutics (NASDAQ: BTAI ) +58% . More news on: BioXcel Therapeutics, Inc., Genprex, Inc., ImmunoGen, Inc., Stocks on the move, , Read more ...
Oppenheimer downgrades LivePerson (NASDAQ: LPSN ) from Outperform to Market Perform after the mixed Q4 results , downside profitability forecast, and CFO transition announcement. More news on: LivePerson, Inc., Tech stocks news, Stocks on the move, Read more ...
Pulse Biosciences (NASDAQ: PLSE ) -44% after disclosing NSE letter from FDA on CellFX system. More news on: Pulse Biosciences, Inc., CarGurus, Inc., LivePerson, Inc., Stocks on the move, , Read more ...
Image source: The Motley Fool. Liveperson Inc (NASDAQ: LPSN) Q4 2019 Earnings Call Feb 13, 2020 , 5:00 p.m. ET Operator Continue reading
News, Short Squeeze, Breakout and More Instantly...
LivePerson and Sycurio partner to bring frictionless, secure payments to digital customer conversations PR Newswire New partnership combines LivePerson's enterprise conversation platform with Sycurio's payment solutions to deliver convenient and secure customer experience...
2024-08-01 07:15:10 ET Barclays analyst issues UNDERWEIGHT recommendation for LPSN on August 1, 2024 05:30AM ET. The previous analyst recommendation was Underweight. LPSN was trading at $1.205 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
LivePerson Announces Second Quarter 2024 Financial Results PR Newswire -- Total Revenue of $79.9M , at the high-end of our guidance range -- -- Adjusted EBITDA above the high-end of our guidance range -- NEW YORK , July 31, 2024 /PRNewsw...